In hepatocellular carcinoma cells, RECQL4 overexpression positively correlated with significantly shorter disease-free survival (DFS) and overall survival (OS) times compared with tissue showing lower RECQL4 expression (Li et al., 2018b). This evidence concerns the gene RECQL4 and hepatocellular carcinoma.